Development of Machine-learning Model to Predict Anticoagulant Use and Type in Geriatric Traumatic Brain Injury Using Coagulation Parameters.

Journal: Neurologia medico-chirurgica
PMID:

Abstract

This study aimed to investigate the patterns of anticoagulation therapy and coagulation parameters and to develop a prediction model to predict the type of anticoagulation therapy in geriatric patients with traumatic brain injury. A retrospective analysis was performed using the nationwide neurotrauma database of Japan. Elderly patients (≥65 years) with traumatic brain injury. Patients were divided into 3 groups based on their daily anticoagulant medication (none, direct oral anticoagulant [DOAC], and vitamin K antagonist [VKA]), and coagulation parameters were compared in each group. We then developed a machine-learning model to predict the anticoagulant using coagulation parameters and visualized the pattern using a heat map. A total of 495 patients were enrolled and divided into 3 groups: none (n = 439), DOACs (n = 37), and VKA (n = 19). Comparing none to DOAC and DOAC to VKA for prothrombin time-international normalized ratio (PT-INR), the mean difference and 95% confidence intervals (CIs) were 0.38 (95% CI: 0.59-0.17) and 1.56 (95% CI: 1.21-1.90), and for activated partial thromboplastin time (APTT), the mean difference between none to DOAC and DOAC to VKA was 3.46 (95% CI: 0.98-5.94) and 95% CI was 7.39 (95% CI: 3.29-11.48). A prediction model for the type of anticoagulant used by PT-INR and APTT was developed using machine-learning methods, and a heat map visually revealed their relationship with acceptable predictive ability. This study revealed the characteristic patterns of coagulation parameters in anticoagulants and a pilot model to predict anticoagulant use.

Authors

  • Gaku Fujiwara
    Department of Neurosurgery, Saiseikai Shiga Hospital, Imperial Gift Foundation Inc.
  • Yohei Okada
    Department of Orthopaedic Surgery, School of Medicine, Sapporo Medical University, Sapporo, Hokkaido, Japan.
  • Eiichi Suehiro
    Department of Neurosurgery, School of Medicine, International University of Health and Welfare, Narita, Japan.
  • Hiroshi Yatsushige
    Department of Neurosurgery, NHO Disaster Medical Center, Tachikawa, Japan.
  • Shin Hirota
    Department of Neurosurgery, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.
  • Shu Hasegawa
    Department of Neurosurgery, Kumamoto Red Cross Hospital, Kumamoto, Japan.
  • Hiroshi Karibe
    Department of Neurosurgery, Sendai City Hospital, Sendai, Miyagi, Japan.
  • Akihiro Miyata
    Department of Neurosurgery, Chiba Emergency Medical Center, Chiba, Japan.
  • Kenya Kawakita
    Emergency Medical Center, Kagawa University Hospital, Kita-gun, Kagawa, Japan.
  • Kohei Haji
    Department of Neurosurgery, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan.
  • Hideo Aihara
    Department of Neurosurgery, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Hyogo, Japan.
  • Shoji Yokobori
    Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Japan.
  • Motoki Inaji
    Department of Neurosurgery, Tokyo Medical and Dental University, Bunkyo-ku, Japan.
  • Takeshi Maeda
    Department of Neurological Surgery, Nihon University School of Medicine, Itabashi-ku, Japan.
  • Takahiro Onuki
    Department of Emergency Medicine, Teikyo University School of Medicine, Itabashi-ku, Japan.
  • Kotaro Oshio
    Department of Neurosurgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Nobukazu Komoribayashi
    Iwate Prefectural Advanced Critical Care and Emergency Center, Iwate Medical University, Yahaba, Iwate, Japan.
  • Michiyasu Suzuki
    Department of Neurosurgery, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan.
  • Naoto Shiomi
    Emergency Medical Care Center, Saiseikai Shiga Hospital, Ritto, Shiga, Japan.